Kristine Ondov

Kristine Ondov has over two decades of experience in finance, primarily within the pharmaceutical industry. Currently serving as Executive Director and Head of US Business Division Finance at Daiichi Sankyo, Inc. since October 2012, Kristine acts as a key business partner to the Commercial Unit and CEO, leading financial data analysis to inform strategic business decisions. Previously, Kristine held roles such as Senior Director of Corporate Finance, where valuable insights were provided to executive management, and Director of Accounting, where processes were re-engineered to enhance efficiency and reporting accuracy. Overall expertise also includes significant positions in financial planning and internal audit at Novartis and ADP, and a foundational role in audit management at PwC. Kristine holds a degree from Villanova University, obtained between 1991 and 1995.